Combined with our data showing elevated IDO1 protein and mRNA expression in grades 2, 3 and 4 RCC compared to normal kidneys (see Figure 1), we conclude that TDO2 and IDO2 are unlikely to be involved in the grade-dependent elevation of the kynurenine pathway that occurs in RCC. The gene discussed is IDO2; the disease is renal cell adenocarcinoma.